Postoperative Management of Thyroidectomy for Graves' Disease

Immediate Postoperative Monitoring

Measure serum calcium and PTH levels within 6 hours after surgery to predict postoperative hypoparathyroidism and hypocalcemia, as recommended by the Endocrine Society 1, 2
PTH measurement ≥1.6 pg/mL measured 4-6 hours after surgery indicates adequate parathyroid function and low risk of clinically significant hypocalcemia, according to the Endocrine Society 1
Perform hourly vital signs and wound inspection for the first 6 hours postoperatively to detect hemorrhage and hematoma formation, as suggested by the American Society of Anesthesiologists 3, 4
Monitor for signs of acute complications using the DESATS acronym: Difficulty swallowing/discomfort, increase in Early warning score, Swelling, Anxiety, Tachypnea/difficulty breathing, and Stridor, as recommended by the American Society of Anesthesiologists 3, 4

For patients <70 years without cardiac disease, start levothyroxine at approximately 1.6 mcg/kg/day, as recommended by the American Thyroid Association 5
For patients >70 years or with cardiac disease, start with a lower dose of 25-50 mcg/day and titrate gradually, as suggested by the American Thyroid Association 5

Recheck TSH and free T4 at 6-8 weeks after initiating or adjusting levothyroxine to allow time to reach steady state, as recommended by the American Thyroid Association 5
Target TSH within the reference range of 0.5-4.5 mIU/L with normal free T4 levels, according to the American Thyroid Association 5
Once stable on an appropriate maintenance dose, monitor TSH every 6-12 months or sooner if symptoms change, as suggested by the American Thyroid Association 5

Increase levothyroxine by 12.5-25 mcg increments if TSH remains elevated above 4.5 mIU/L, as recommended by the American Thyroid Association 5
Decrease levothyroxine by 12.5-25 mcg if TSH falls below 0.1-0.45 mIU/L to prevent iatrogenic hyperthyroidism, according to the American Thyroid Association 5

Never delay calcium and PTH measurement beyond the first 6 hours postoperatively, as this is the critical window for predicting clinically significant hypocalcemia, as recommended by the Endocrine Society 1, 2
Avoid adjusting levothyroxine doses more frequently than every 6-8 weeks, as TSH requires this time to reach steady state after dose changes, as suggested by the American Thyroid Association 5
Do not undertreat or overtreat with levothyroxine: approximately 25% of patients are inadvertently maintained on doses sufficient to fully suppress TSH, increasing risks for atrial fibrillation, osteoporosis, and cardiac complications, according to the American Thyroid Association 5